Stelac Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Stelac Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,559	Closed	-$419K	–	115
2023 Q2	$419K	Sell	6,559 -409	-6%	-$27.4K	0.19%	96
2023 Q1	$483K	Buy	6,968 +6	+0.1%	+$423	0.21%	84
2022 Q4	$501K	Sell	6,962 -704	-9%	-$53.1K	0.23%	75
2022 Q3	$546K	Hold	7,666	–	–	0.25%	63
2022 Q2	$590K	Buy	7,666 +4,914	+179%	+$374K	0.24%	59
2022 Q1	$201K	Sell	2,752 -5,163	-65%	-$347K	0.07%	101
2021 Q4	$494K	Sell	7,915 -415	-5%	-$24.3K	0.13%	92
2021 Q3	$493K	Sell	8,330 -326	-4%	-$21.5K	0.13%	115
2021 Q2	$578K	Buy	8,656 +5,058	+141%	+$330K	0.13%	120
2021 Q1	$227K	Sell	3,598 -2,326	-39%	-$145K	0.08%	145
2020 Q4	$367K	Buy	5,924 +2,703	+84%	+$166K	0.09%	129
2020 Q3	$194K	Buy	3,221 +84	+3%	+$5.06K	0.07%	132
2020 Q2	$184K	Buy	+3,137	New	+$188K	0.07%	114
2017 Q4	–	Sell	-1,779	Closed	-$113K	–	69
2017 Q3	$113K	Sell	1,779 -1,130	-39%	-$66K	0.03%	76
2017 Q2	$162K	Hold	2,909	–	–	0.05%	57
2017 Q1	$158K	Buy	2,909 +1,130	+64%	+$62K	0.05%	63
2016 Q4	$104K	Buy	+1,779	New	+$97.3K	0.03%	70

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Stelac Advisory Services's BMY Position: Q3 2023 in Review

Stelac Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 6,559 shares — an estimated $419K sold.

Stelac Advisory Services first reported a position in BMY in Q4 2016 and held it in 17 quarters. The position peaked at $590K in Q2 2022. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Stelac Advisory Services reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Stelac Advisory Services sold 6,559 Bristol-Myers Squibb shares in Q3 2023, an estimated $419K.
Stelac Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 17 quarters.
Stelac Advisory Services's Bristol-Myers Squibb position peaked at $590K in Q2 2022.
2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Stelac Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.